JP2004538280A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004538280A5 JP2004538280A5 JP2003513549A JP2003513549A JP2004538280A5 JP 2004538280 A5 JP2004538280 A5 JP 2004538280A5 JP 2003513549 A JP2003513549 A JP 2003513549A JP 2003513549 A JP2003513549 A JP 2003513549A JP 2004538280 A5 JP2004538280 A5 JP 2004538280A5
- Authority
- JP
- Japan
- Prior art keywords
- hydrogen
- alkyl
- nso
- tetrazol
- remainder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 125000004299 tetrazol-5-yl group Chemical group [H]N1N=NC(*)=N1 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30576201P | 2001-07-16 | 2001-07-16 | |
| PCT/EP2002/007733 WO2003007941A1 (en) | 2001-07-16 | 2002-07-11 | 2 pyrrolidone derivatives as prostanoid agonists |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008155799A Division JP5003601B2 (ja) | 2001-07-16 | 2008-06-13 | プロスタノイドアゴニストとしての２ピロリドン誘導体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004538280A JP2004538280A (ja) | 2004-12-24 |
| JP2004538280A5 true JP2004538280A5 (enExample) | 2008-10-30 |
| JP4211605B2 JP4211605B2 (ja) | 2009-01-21 |
Family
ID=23182225
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003513549A Expired - Fee Related JP4211605B2 (ja) | 2001-07-16 | 2002-07-11 | プロスタノイドアゴニストとしての２ピロリドン誘導体 |
| JP2008155799A Expired - Fee Related JP5003601B2 (ja) | 2001-07-16 | 2008-06-13 | プロスタノイドアゴニストとしての２ピロリドン誘導体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008155799A Expired - Fee Related JP5003601B2 (ja) | 2001-07-16 | 2008-06-13 | プロスタノイドアゴニストとしての２ピロリドン誘導体 |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US6849657B2 (enExample) |
| EP (1) | EP1408961B1 (enExample) |
| JP (2) | JP4211605B2 (enExample) |
| KR (1) | KR100702368B1 (enExample) |
| CN (1) | CN100371322C (enExample) |
| AT (1) | ATE366571T1 (enExample) |
| AU (1) | AU2002328338C1 (enExample) |
| BR (1) | BR0211167A (enExample) |
| CA (1) | CA2451393C (enExample) |
| DE (1) | DE60221130T2 (enExample) |
| DK (1) | DK1408961T3 (enExample) |
| ES (1) | ES2289140T3 (enExample) |
| GT (1) | GT200200152A (enExample) |
| MX (1) | MXPA04000454A (enExample) |
| PA (1) | PA8550501A1 (enExample) |
| PE (1) | PE20030286A1 (enExample) |
| PL (1) | PL215425B1 (enExample) |
| PT (1) | PT1408961E (enExample) |
| RU (1) | RU2296122C2 (enExample) |
| WO (1) | WO2003007941A1 (enExample) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA04000454A (es) * | 2001-07-16 | 2004-03-18 | Hoffmann La Roche | Derivados de 2-pirrolidona como agonistas de prostanoides. |
| US7608637B2 (en) | 2001-07-23 | 2009-10-27 | Ono Pharmaceutical Co., Ltd. | Pharmaceutical composition for treatment of diseases associated with decrease in bone mass comprising EP4 agonist as the active ingredient |
| WO2003047417A2 (en) * | 2001-12-03 | 2003-06-12 | Merck & Co., Inc. | Ep4 receptor agonist, compositions and methods thereof |
| NZ535024A (en) * | 2002-03-05 | 2006-10-27 | Ono Pharmaceutical Co | 8-azaprostaglandin derivative compound and agent comprising the compound as active ingredient |
| US6573294B1 (en) | 2002-05-14 | 2003-06-03 | Allergan, Inc. | 8-azaprostaglandin analogs as agents for lowering intraocular pressure |
| CA2483555A1 (en) | 2002-06-10 | 2003-12-18 | Applied Research Systems Ars Holding N.V. | Gamma lactams as prostaglandin agonists and use thereof |
| WO2004058198A1 (ja) | 2002-12-26 | 2004-07-15 | Dow Corning Toray Co., Ltd. | 毛髪用組成物 |
| CA2511255C (en) | 2003-01-10 | 2009-04-07 | F. Hoffmann-La Roche Ag | 2-piperidone derivatives as prostaglandin agonists |
| WO2004078103A2 (en) * | 2003-03-03 | 2004-09-16 | Applied Research Systems Ars Holding N.V. | G-lactam derivatives as prostaglandin agonists |
| US6734206B1 (en) * | 2003-06-02 | 2004-05-11 | Allergan, Inc. | 3-oxa-8-azaprostaglandin analogs as agents for lowering intraocular pressure |
| US6734201B1 (en) | 2003-06-02 | 2004-05-11 | Allergan, Inc. | 8-Azaprostaglandin carbonate and thiocarbonate analogs as therapeutic agents |
| AU2005252171A1 (en) * | 2004-06-04 | 2005-12-22 | Allergan, Inc. | Piperidinyl prostaglandin analogs as ocular hypotensive agents |
| AU2005313380A1 (en) | 2004-12-06 | 2006-06-15 | Merck Serono Sa | Pyrrolidin-2-one derivatives for use as DP1 receptor agonists |
| WO2006080323A1 (ja) * | 2005-01-27 | 2006-08-03 | Asahi Kasei Pharma Corporation | ヘテロ６員環化合物及びその用途 |
| US7531533B2 (en) | 2005-01-27 | 2009-05-12 | Asahi Kasei Pharma Corporation | 6-Membered heterocyclic compound and use thereof |
| US8524731B2 (en) * | 2005-03-07 | 2013-09-03 | The University Of Chicago | Use of opioid antagonists to attenuate endothelial cell proliferation and migration |
| US8372912B2 (en) * | 2005-08-12 | 2013-02-12 | Eastman Chemical Company | Polyvinyl chloride compositions |
| EP2057241B1 (en) * | 2006-08-30 | 2012-08-01 | Eastman Chemical Company | Terephthalates as plasticizers in vinyl acetate polymer compositions |
| CA2661173C (en) | 2006-08-30 | 2012-08-28 | Eastman Chemical Company | Sealant compositions having a novel plasticizer |
| US8507545B2 (en) | 2007-05-08 | 2013-08-13 | National University Corporation, Hamamatsu University School Of Medicine | Cytotoxic T cell activator comprising EP4 agonist |
| US20120142684A1 (en) * | 2010-12-02 | 2012-06-07 | Allergan, Inc. | Compounds and methods for skin repair |
| JP6052175B2 (ja) | 2011-08-02 | 2016-12-27 | 小野薬品工業株式会社 | 左室拡張機能改善剤 |
| CN107802623B (zh) | 2012-07-19 | 2020-10-30 | 开曼化学股份有限公司 | 用于ep4介导的骨相关疾病和病症的二氟内酰胺组合物 |
| BR112015023080A2 (pt) | 2013-03-15 | 2017-07-18 | Cayman Chemical Co Inc | composto, composição farmacêutica, e, método para tratamento de doenças |
| WO2014144610A1 (en) | 2013-03-15 | 2014-09-18 | Cayman Chemical Company, Inc. | Lactam compounds as ep4 receptor-selective agonists for use in the treatment of ep4-mediated diseases and conditions |
| JP6368351B2 (ja) | 2013-03-15 | 2018-08-01 | ケイマン ケミカル カンパニー， インコーポレーテッド | ジフルオロラクタムアナログを合成する方法 |
| WO2015009991A2 (en) | 2013-07-19 | 2015-01-22 | Cayman Chemical Company, Inc. | Methods, systems, and compositions for promoting bone growth |
| JP6896106B2 (ja) | 2017-12-25 | 2021-06-30 | 旭化成ファーマ株式会社 | 含窒素６員環化合物 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3975399A (en) * | 1974-08-06 | 1976-08-17 | E. I. Du Pont De Nemours And Company | 1,5-Disubstituted-2-pyrrolidinones, -3-pyrrolin-2-ones, and -4-pyrrolin-2-ones |
| US4113873A (en) * | 1975-04-26 | 1978-09-12 | Tanabe Seiyaku Co. Ltd. | 8-azaprostanoic acid derivatives |
| NL7604330A (nl) * | 1975-04-28 | 1976-11-01 | Syntex Inc | Werkwijze voor de bereiding van 8-azaprostaan- zuurderivaten. |
| DE2556326A1 (de) | 1975-12-13 | 1977-06-23 | Hoechst Ag | Neue pyrrolidone und verfahren zu ihrer herstellung |
| DE2528664A1 (de) | 1975-06-27 | 1977-01-13 | Hoechst Ag | Pyrrolidone und verfahren zu ihrer herstellung |
| IL49325A (en) * | 1976-03-31 | 1979-11-30 | Labaz | 8-aza-11-deoxy-pge1 derivatives,their preparation and pharmaceutical compositions containing them |
| DE2619638A1 (de) | 1976-05-04 | 1977-11-17 | Hoechst Ag | Pyrrolidone und verfahren zu ihrer herstellung |
| US4177346A (en) * | 1976-08-06 | 1979-12-04 | Pfizer Inc. | 1,5-Disubstituted-2-pyrrolidones |
| US4320136A (en) * | 1980-08-11 | 1982-03-16 | E. I. Du Pont De Nemours And Company | 8-Aza-16,16-difluoroprostanoids |
| JP2571250B2 (ja) * | 1987-01-19 | 1997-01-16 | 三共株式会社 | プロスタグランジン化合物 |
| SE9702681D0 (sv) * | 1997-07-10 | 1997-07-10 | Pharmacia & Upjohn Ab | Method and composition for treatment of impotence |
| TWI249520B (en) * | 1998-07-15 | 2006-02-21 | Ono Pharmaceutical Co | 5-Thia-omega-substituted phenyl prostaglandin E derivatives, method for producing the same and medicines containing the same as the active ingredient |
| JP2002527400A (ja) | 1998-10-15 | 2002-08-27 | メルク エンド カムパニー インコーポレーテッド | 骨形成刺激方法 |
| WO2000021532A1 (en) | 1998-10-15 | 2000-04-20 | Merck & Co., Inc. | Methods for inhibiting bone resorption |
| US6211226B1 (en) * | 1998-12-17 | 2001-04-03 | Alcon Laboratories, Inc. | 11-Aza prostaglandins for the treatment of glaucoma and ocular hypertension |
| TWI247606B (en) * | 1999-11-24 | 2006-01-21 | Ono Pharmaceutical Co | Treating agent for osteopenic diseases |
| AP2002002555A0 (en) | 1999-12-22 | 2002-06-30 | Pfizer Prod Inc | EP4 Receptor selective agonists in the treatment of osteoporosis. |
| PT1132086E (pt) * | 2000-01-31 | 2006-09-29 | Pfizer Prod Inc | Utilizacao de agonistas selectivos para o receptor da prostaglandina (pge2) 4 (ep4) para o tratamento de falha renal aguda e cronica |
| WO2001062724A1 (fr) * | 2000-02-28 | 2001-08-30 | Taisho Pharmaceutical Co., Ltd. | Derives de prostaglandine e |
| AU2001290250A1 (en) | 2000-09-21 | 2002-04-02 | Ono Pharmaceutical Co. Ltd. | Ep4 receptor agonists containing 8-azaprostaglandin derivatives as the active ingredient |
| DK1339678T3 (da) * | 2000-11-27 | 2008-02-04 | Pfizer Prod Inc | Selektive agonister til EP4-receptor til behandling af osteoporose |
| MXPA04000454A (es) * | 2001-07-16 | 2004-03-18 | Hoffmann La Roche | Derivados de 2-pirrolidona como agonistas de prostanoides. |
-
2002
- 2002-07-11 MX MXPA04000454A patent/MXPA04000454A/es active IP Right Grant
- 2002-07-11 AU AU2002328338A patent/AU2002328338C1/en not_active Ceased
- 2002-07-11 RU RU2004104627/04A patent/RU2296122C2/ru not_active IP Right Cessation
- 2002-07-11 CN CNB028142675A patent/CN100371322C/zh not_active Expired - Fee Related
- 2002-07-11 DE DE60221130T patent/DE60221130T2/de not_active Expired - Lifetime
- 2002-07-11 AT AT02762347T patent/ATE366571T1/de active
- 2002-07-11 ES ES02762347T patent/ES2289140T3/es not_active Expired - Lifetime
- 2002-07-11 KR KR1020047000756A patent/KR100702368B1/ko not_active Expired - Fee Related
- 2002-07-11 EP EP02762347A patent/EP1408961B1/en not_active Expired - Lifetime
- 2002-07-11 CA CA2451393A patent/CA2451393C/en not_active Expired - Fee Related
- 2002-07-11 DK DK02762347T patent/DK1408961T3/da active
- 2002-07-11 PL PL367696A patent/PL215425B1/pl not_active IP Right Cessation
- 2002-07-11 JP JP2003513549A patent/JP4211605B2/ja not_active Expired - Fee Related
- 2002-07-11 BR BR0211167-5A patent/BR0211167A/pt not_active IP Right Cessation
- 2002-07-11 PT PT02762347T patent/PT1408961E/pt unknown
- 2002-07-11 WO PCT/EP2002/007733 patent/WO2003007941A1/en not_active Ceased
- 2002-07-15 PA PA20028550501A patent/PA8550501A1/es unknown
- 2002-07-15 PE PE2002000629A patent/PE20030286A1/es not_active Application Discontinuation
- 2002-07-15 GT GT200200152A patent/GT200200152A/es unknown
- 2002-07-16 US US10/197,279 patent/US6849657B2/en not_active Expired - Lifetime
-
2008
- 2008-06-13 JP JP2008155799A patent/JP5003601B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004538280A5 (enExample) | ||
| JPH1180090A5 (enExample) | ||
| JP2007510619A5 (enExample) | ||
| JP2003510305A5 (enExample) | ||
| JP2003530368A5 (enExample) | ||
| JP2007503487A5 (enExample) | ||
| JP2003531118A5 (enExample) | ||
| JP2004501853A5 (enExample) | ||
| JP2002541233A5 (enExample) | ||
| JP2000086767A5 (enExample) | ||
| JP2003508388A5 (enExample) | ||
| JP2002518384A5 (enExample) | ||
| JP2006514114A5 (enExample) | ||
| JP2003206485A5 (enExample) | ||
| JP2003534359A5 (enExample) | ||
| JP2006503143A5 (enExample) | ||
| JP2005533904A5 (enExample) | ||
| JP2009504862A5 (enExample) | ||
| JPH1067941A5 (enExample) | ||
| EP1236744A3 (en) | Guanidin-group containing polymer, cosmetic employing same and method of preparing same | |
| JP2003506447A5 (enExample) | ||
| RU94019411A (ru) | Эфиры хинук лидина, промежуточные соединения для их синтеза, фармацевтическая композиция и способ лечения | |
| JP2001518468A5 (enExample) | ||
| JP2004149774A5 (enExample) | ||
| JP2003532677A5 (enExample) |